drugset / Trial / NCT06524011

Stromal Vascular Fraction Enriched PRP in Treatment of Post-acne Scars

NCT06524011

Not yet recruiting 30 enrolled Zagazig University
RandomizedParallel-groupSingle-blindTreatment

Summary

in a split face fashion, 30 patients will be randomized into 3 groups: Group A: rt side treated with SVF enriched PRP, lt side treated with prp Group B: rt side treated with SVF enriched PRP, lt side treated with SVF Group C: rt side treated with PRP, lt side treated with SVF

Timeline

Start
2024-12
Primary completion
2025-12
Completion
2026-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified
Subject Rexlemestrocel-L Cell therapy

Indications

No indication recorded.